These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
557 related articles for article (PubMed ID: 17596404)
21. SH2-containing inositol phosphatase 2 predominantly regulates Akt2, and not Akt1, phosphorylation at the plasma membrane in response to insulin in 3T3-L1 adipocytes. Sasaoka T; Wada T; Fukui K; Murakami S; Ishihara H; Suzuki R; Tobe K; Kadowaki T; Kobayashi M J Biol Chem; 2004 Apr; 279(15):14835-43. PubMed ID: 14744864 [TBL] [Abstract][Full Text] [Related]
22. The SH2 domain containing inositol polyphosphate 5-phosphatase-2: SHIP2. Dyson JM; Kong AM; Wiradjaja F; Astle MV; Gurung R; Mitchell CA Int J Biochem Cell Biol; 2005 Nov; 37(11):2260-5. PubMed ID: 15964236 [TBL] [Abstract][Full Text] [Related]
23. Transcriptional profiling of C2C12 myotubes in response to SHIP2 depletion and insulin stimulation. Huard C; Martinez RV; Ross C; Johnson JW; Zhong W; Hill AA; Kim R; Paulsen JE; Shih HH Genomics; 2007 Feb; 89(2):270-9. PubMed ID: 17123777 [TBL] [Abstract][Full Text] [Related]
24. Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Sleeman MW; Wortley KE; Lai KM; Gowen LC; Kintner J; Kline WO; Garcia K; Stitt TN; Yancopoulos GD; Wiegand SJ; Glass DJ Nat Med; 2005 Feb; 11(2):199-205. PubMed ID: 15654325 [TBL] [Abstract][Full Text] [Related]
25. SH2 domain-containing inositol 5-phosphatase (SHIP2) regulates de-novo lipogenesis and secretion of apoB100 containing lipoproteins in HepG2 cells. Gorgani-Firuzjaee S; Khatami S; Adeli K; Meshkani R Biochem Biophys Res Commun; 2015 Sep; 464(4):1028-1033. PubMed ID: 26188518 [TBL] [Abstract][Full Text] [Related]
26. Perturbation of glucose flux in the liver by decreasing F26P2 levels causes hepatic insulin resistance and hyperglycemia. Wu C; Khan SA; Peng LJ; Li H; Carmella SG; Lange AJ Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E536-43. PubMed ID: 16621898 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of SH2-domain-containing inositol 5-phosphatase (SHIP2) ameliorates palmitate induced-apoptosis through regulating Akt/FOXO1 pathway and ROS production in HepG2 cells. Gorgani-Firuzjaee S; Adeli K; Meshkani R Biochem Biophys Res Commun; 2015 Aug; 464(2):441-6. PubMed ID: 26123392 [TBL] [Abstract][Full Text] [Related]
28. Impact of SRC homology 2-containing inositol 5'-phosphatase 2 gene polymorphisms detected in a Japanese population on insulin signaling. Kagawa S; Sasaoka T; Yaguchi S; Ishihara H; Tsuneki H; Murakami S; Fukui K; Wada T; Kobayashi S; Kimura I; Kobayashi M J Clin Endocrinol Metab; 2005 May; 90(5):2911-9. PubMed ID: 15687335 [TBL] [Abstract][Full Text] [Related]
29. The SH2 domain containing inositol 5-phosphatase SHIP2 controls phosphatidylinositol 3,4,5-trisphosphate levels in CHO-IR cells stimulated by insulin. Blero D; De Smedt F; Pesesse X; Paternotte N; Moreau C; Payrastre B; Erneux C Biochem Biophys Res Commun; 2001 Apr; 282(3):839-43. PubMed ID: 11401540 [TBL] [Abstract][Full Text] [Related]
30. Regulation of PDGF-stimulated SHIP2 tyrosine phosphorylation and association with Shc in 3T3-L1 preadipocytes. Artemenko Y; Gagnon A; Ibrahim S; Sorisky A J Cell Physiol; 2007 Jun; 211(3):598-607. PubMed ID: 17219406 [TBL] [Abstract][Full Text] [Related]
31. Impact of Src homology 2-containing inositol 5'-phosphatase 2 on the regulation of insulin signaling leading to protein synthesis in 3T3-L1 adipocytes cultured with excess amino acids. Murakami S; Sasaoka T; Wada T; Fukui K; Nagira K; Ishihara H; Usui I; Kobayashi M Endocrinology; 2004 Jul; 145(7):3215-23. PubMed ID: 15044364 [TBL] [Abstract][Full Text] [Related]
32. Rational design and synthesis of 4-substituted 2-pyridin-2-ylamides with inhibitory effects on SH2 domain-containing inositol 5'-phosphatase 2 (SHIP2). Ichihara Y; Fujimura R; Tsuneki H; Wada T; Okamoto K; Gouda H; Hirono S; Sugimoto K; Matsuya Y; Sasaoka T; Toyooka N Eur J Med Chem; 2013 Apr; 62():649-60. PubMed ID: 23434638 [TBL] [Abstract][Full Text] [Related]
33. Caveolin gene transfer improves glucose metabolism in diabetic mice. Otsu K; Toya Y; Oshikawa J; Kurotani R; Yazawa T; Sato M; Yokoyama U; Umemura S; Minamisawa S; Okumura S; Ishikawa Y Am J Physiol Cell Physiol; 2010 Mar; 298(3):C450-6. PubMed ID: 19923424 [TBL] [Abstract][Full Text] [Related]
34. Chronic suppression of insulin by diazoxide alters the activities of key enzymes regulating hepatic gluconeogenesis in Zucker rats. Alemzadeh R; Holshouser S; Massey P; Koontz J Eur J Endocrinol; 2002 Jun; 146(6):871-9. PubMed ID: 12039709 [TBL] [Abstract][Full Text] [Related]